]MCYST-LR, sublethal, i.v.) were measured in mice. Plasma elimination was biexponential with a-and /-phase half-lives of 0.8 and 6.9 min, respectively. The apparent volume of distribution of the a-phase was 10 ml and the area under the curve was 1036 pmol min/ml. At 60 min, liver contained 67 ± 4% of dose. Through the 6 day study the amount of hepatic radioactivity did not change while 23.7 ± 1.7% of the dose was excreted; 9.2 + 1 and 14.5 ± 1.1% in urine and feces, respectively. Approximately 60% of the urine and fecal radiolabel 6 and 12 hr post injection was the parent toxin. Hepatic cytosol, which contained 70 ± 2% of the hepatic radiolabel (1 hr through 6 days), was prepared for HPLC analysis by heat denaturation, pronase digestion, and C-18 Sep Pak extraction. One hr post exposure, 35 + 2% of the radiolabel was insoluble or C-18 Sep Pak-bound; 43 ± 3% was associated with a peak of retention time (rt) 6.6 min, and 16 ± 3% with parent toxin. After 6 days, 8 ± 1% was C-18 Sep Pak-bound or insoluble; 5 ± 0% occurred at rt 6.6 min, 17 ± 1% with (continued on back) 20 phase half-lives of 0.8 and 6.9 min, respectively. The apparent volume of distribution of the #-phase was 10 ml and the area under the curve was 1036 pmol min/ml. At 60 min, liver contained 67 ± 4% of dose. Through the 6 day study the amount of hepatic radioactivity did not change while 23.7 ± 1.7% of the dose was excreted; 9.2 ± 1 and 14.5 ± 1.1% in urine and feces,
respectively. Approximately 60% of the urine and fecal radiolabel 6 and 12 hr post injection was the parent toxin.
Hepatic cytosol, which contained 70 ± 2% of the hepatic radiolabel (1 hr through 6 days), was prepared for HPLC analysis by heat denaturation, pronase digestion, and C-18 Sep Pak extraction. One hr post exposure, 35 ± 2% of the radiolabel was insoluble or C-18 Sep Pak-bound; 43 ± 3% was associated with a peak of retention time (rt) 6.6 min, and 16 ± 3% with parent toxin. After 6 days, 8 ± 1% was C-18 Sep Pak-bound or insoluble; 5 ± 0% occurred at rt 6.6 min, 17 ± 1% with parent, and 60 ± 2%
was associated with rt 8.1 min. Two other radioactive peaks, rt 4.9 and 5.6 min, appeared transiently. Analysis of hepatic cytosol by desalting chromatography under native and denaturing conditions revealed that all of the radiolabel was associated with cytosolic components, and 83 ± 5% was covalently bound through 1 day. By day 6 the amount covalently bound decreased to 3 42 ± 11%. This study is the first to describe the long-term hepatic retention of MCYST toxin and documents putative detoxication products.
Microcystin-LR (MCYST-LR), isolated from the cyanobacterium
Microcystis aeruginosa strain PCC-7820, is one of several related cyclic peptide hepatotoxins (Botes et a!., 1985; RinehatL er al., 1988) . This family of toxins has been implicated in the death of both wild and domestic animals that consumed water containing dense blooms of blue-green alga (Soll and Williams, 1985; Beasley et al., 1989; Galey et al., 1987) . A consistent pathological finding after lethal exposure to toxin is blood-engorged livers with diffuse hepatic centrilobular necrosis (Konst et al., 1965; Adams et al., 1988; Jackson et al., 1984; Theiss et al., 1988) .
The proposed cause of death is massive intrahepatic hemorrhage Theiss et al., 1988) . Human fatality has not been associated with the MCYST toxins; however, a heavy bloom of M. aeruginosa in a reservoir at Malpus Dam, Australia, was correlated with a rise in plasma gamma-glutamyl transpepidase in humans, suggestive of hepatic injury (Falconer et al., 1983) .
While information has been published concerning the tissue distribution of MCYST toxins in rat (Falconer er al., 1986; Pace et al., 1990b) and in mouse (Robinson et al., 1989; Brooks and Codd, 1987; Runnegar et al., 1986) , the pharmacokinetics have not been completely described in either species. The reports agree that liver, the target organ, accumulates toxin; however, the time required for maximal accumulation varies from 1 min (Brooks and Codd, 1987) to 60 min (Robinson et al., 1989) (Jungermann and Katz, 1989) ; liver specificity could be explained by prerequis.ite hepatic metabolism for toxicity; and neonatal rats and mice are not as susceptible to the MCYST toxins (Foxall and Sasner, 1981; Stoner et al., 1989) , possibly because many metabolic enzymes are regulated developmentally (Pelkonen, 1979 was produced by chemical tritiation of MCYST-LR (Matsuo and Narita, 1975) and purified by reverse-phase HPLC (99% radiochemical purity, 194 mCi/mmol, Robinson et al., 1989) . Heparin (1000 U/ml, 50 4l) was added to the blood and plasma was separated by centrifugation at 700 x g for 10 min. At 1, 3, 6, 10, 15, 20, 30, 40 , and 60 min post injection, tissues (heart, lung, liver, gut, kidney, and spleen) were removed, weighed, Urine and feces were collected at 6 and 12 hr and 1, 2, 3, 4, 5, and 6 days post exposure. Sodium fluoride (25 mg) was added to the urine samples and 100-500 Al was analyzed for radioactivity.
The calculated limit of detection in urine was 1 pmol/ml. Ground liver samples (1.5-2 g) were homogenized with a motor-driven, teflon pestle in 5 ml of 100 mM tris(hydroxymethyl)aminomethane (Tris-Cl), pH 7.2, and centrifuged at 10,000 x g for 10 min. The pellet was rehomogenized (3 ml buffer) and recentrifuged. The combined supernatants were centrifuged at 100,000 x g to obtain the cytosolic fraction. The h:patic cytosol was prepared for HPLC analysis as described by Pace et al. (1990c) . The cytosol (1 ml, i8.3 ± 1 mg/ml) "as heat-denatured for 30 min at 90 0 C after addition of an equal volume of 100 mM potassium phosphate, pH 7.5. Pronase (1 mg in 1 ml buffer, Boehringer Mannhiem Biochemicals, Indianapolis, IN) was added to the heat-denatured slurry and the sample incubated for 1 hr at 37 0 C. Hepatic cytosol (0.5 ml) was denatured by the addition of solid urea and SDS, final concentration 6 M and 0.1%, respectively, prior to application (1 ml) to the columns. Fractions (1 ml)
were collected and analyzed for radioactivity by liquid scintillation.
Plasma chemistry and histology. Plasma collected from either control mice (1 hr or 6 days post injection of saline) or toxin-treated mice (1, 6, and 12 hr and 1, 2, 4, and 6 days post injection) was analyzed on a COBAS BIO Centrifugal Analyzer In liver, there was a rapid uptake of radiolabel, which reached a maximum accumulation of 521 ± 14 pmol/g (71 ± 3% of dose) by 30 min. The half-life of uptake was 6.8 min. In kidney, the maximum concentration was achieved at 3 mit, (9G t 7 pmol/g, 4.6 ± 0.6% of dose) followed by a decline in concentration until 20 min. The amount of radiolabel in gut reached a maximum at 30-40 min. In lung and carcass, the maximum amounts were measured at 3 min, after which the concentration declined. Spleen and heart did not contain measurable amounts of radioactivity. The distribution of radiolabel to tissues with time, presented as percent of injected dose, is shown in Table 1 .
The overall recovery of radiolabel ranged from 74 to 101% of dose. The partition coefficients or distribution ratios (R, ratio of mean concentration of toxin equivalents in tissue to that in plasma at steady state, 30 min) were 206, 4, and 11 for liver, kidney, and intestine, respectively, indicating accumulation of radiolabel in these tissues (R, was >1), but not in carcass.
Excretion of [H]MCYST-LR in urine and feces. Six days post
exposure to 35 gg/kg [ 3 H]MCYST-LR, 23.7 ± 1.7% of the radiolabel had been excreted (Fig 3, Panel A) ; 9.2 ± 1.0% and 14.5 ± 1.1% via urine and feces, respectively. The percent of dose that appeared in feces or urine per collection interval (midpoint) is given in Fig. 3 , panels B and C, respectively. The rate of excretion via feces was 0.9 and 0.5% per hr for 6 and 12 hr, and ca. 1% per day for the remaining 6 days. Within the first 12 hr, 74% of cumulative urinary excretion had occurred.
Analysis c-f urinary and fecal matabolites. Urine samples collected 6 and 12 hr after toxin exposure were analyzed for metabolites by C-18 HPLC. At 6 hr, 6 ± 1% of the injected radiolabel was found in urine; and 63 ± 2% (n=7) of that was parent toxin, rt 9.4 min (Fig. 4, panel B) .
The major portion of the remaining radiolabel (30 ± 4%) was associated with a peak of rt 4.5 min. There were also several minor peaks detected in some of the samples. Between 6 and 12 hr, 1.5 ± 0.4% of the radiolabel was excreted in urine. In the two samples that contained sufficient radioactivity to be analyzed, the profile was similar to that seen at 6 hr; 35% at rt 4.5 min and 63% as parent. Later time points did not contain sufficient radiolabel for anaLysis.
Feces collected 6 hr post injection contained 5 ± 1% of the injected radiolabel, 69 ± 3% of which was recovered for HPLC analysis. A typical radioactive profile for a 6-hr fecal sample is shown in Fig. 4 , panel C. Parent toxin, rt 9.4 min, comprised 63 ± 8% (n=6) of the radioactivity with the residual in five other peaks (legend of Fig. 4) . Between 6 and 12 hr, 2.9 ± 0.3% of the dose appeared in feces; 52 ± 4% was recovered for HPLC analysis, of which 76 ± 8% (n=6) was associated with parent toxin. Later time points did not contain sufficient radiolabel for analysis.
HPLC analysis of hepatic-cytosolic radiolabel. The total amount of liver-sequestered radiolabel did not change from 1 hr (67 ± 4%, n=6) to 6 days (66 ± 2%, n-3) post-exposure, while carcass-associated radiolabel, comprised of all tissues except liver, decreased from 15 ± 2% at 1 hr to trace amounts by 4 days.
The subcellular distribution of hepatic radiolabel also remained unchanged over 6 days; the 10,000 x g pellet, consisting of unbroken cells, mitochondria and plasma membrane, contained 13 ± 1%; the 100,000 x g pellet, composed mainly of microsomes, residual plasma membrane, and mitochondria, contained 12 ± 1%;
and the cytosol contained 70 ± 2% of the hepatic radioactivity.
After heat denaturation, pronase treatment and C-18 Sep Pak extraction, the Sep Pak-eluted radioactivity was separated into five radioactive, HPLC peaks of rt 4.9, 5.6, 6.6, 8.1, and 9.4 min, the-latter being the rt of [ 3 H]MCYST-LR (Fig. 4 , Panels D-
The percent distribution of hepatic-cytosolic radiolabel with respect to time is presented in Table 2 . The portion of radiolabel that remained bound to the C-18 Sep Pak resin plus that which remained insoluble decreased between 12 hr and 4 days, as did the 6.6 min HPLC peak. The 8.1-min fraction steadily increased and the peaks of rt 4.9-and 5.6-min appeared at 12 and 6 hr, and disappeared after 2 and 6 days, respectively.
Analysis of hepatic cytosol under native and denaturing
conditions by desalting chromatography. Pronase digcztion of hepatic cytosol was the only method we found to be effective in separating radiolabel from cytosolic protein (Pace et al., 1990c) . To further explore this observation, hepatic cytoso. was analyzed by desalting chromatography under native conditions.
From 1 hr through 6 days post injection, all cytosolic radiolabel eluted in the void volume of a DG10 desalting column suggesting association with high molecular weight components, while free [ 3 H]MCYST-LR eluted as a lower molecular weight component (Fig.   5 ).
To determine if radiolabel was covalently bound to the high molecular weight-cytosolic components, the samples were first denatured with 6 M urea and 1% SDS and then chromatographed.
[ 3 H)MCYST-LR eluted in fractions 4 and 5, as did a portion of the cytosolic radiolabel (Fig 6) . The remaining radiolabel eluted in fractions 2 and 3 indicating it was covalently bound to cytosolic components. The amount of radiolabel that was covalently bound from 1 hr through 6 days post exposure is given in Table 3 . The percent bound did not change from 1 hr through 1 day. At 2 days post exposure the amount of covalently bound radioactivity began to decrease to a value of 42% ± 11 by 6 days.
Discussion
One of the objectives of this study was to measure excretion and hepatic metabolism of [3H]MCYST-LR.
We chose a dose of the hepatotoxin which resulted in minimal toxic effects to avoid inhibition of these processes. The only indication of toxicity was a transient rise in several serum enzymes. Histologically, livers appeared normal 1 min through 6 days post injection.
The kinetic parameters defined in this study indicate that plasma elimination did not reflect toxicity, as liver, the target organ, accumulated the toxin. Hepatic accumulation of radiolabeled MCYST toxins has been observed by several groups (Pace et al., 1990c; Robinson et al., 1989; Brocka and Codd, 1987; Falconer et al., 1986) ; however, this is the first time that the long-term hepatic retention of radiolabel has been documented. Runnegar et al. (1986) , who studied liver retention 24 hr post injection of various doses of [1 25 I]MCYST-YM, concluded that livers that were relatively normal by histological examination excreted almost all of the hepatic radioactivity, while those that exhibited more extensive damage retained the labeled toxin. It is not clear whether the discrepancy between their study and the data presented here is due to the difference in toxin variants or to the nature of the radiolabel attached to the compound. We found that the amount of radiolabel sequestered by liver peaked at 30 min and did not change thereafter over the 6-day study. All of the sequcstered hepatic-cytosolic radiolabel appeared to be bound to high molecular weight components, most unbound Lr free toxin could influence partitioning (Pang, 1983) .
Also, protein-bound toxin or metabolite would probably not follow typical xenobiotic elimination pathways, which could explain the long hepatic retention.
Fecal elimination, after the first 12 hr, was constant at -1% per day; but the amount of hepatic radiolabel did not change over the course of the study. There was, however, a decrease in carcass (all tissues except liver) radioactivity over time, but it is not clear whether the radiolabel was eliminated directly or via bile. It is possible that toxin was taken up by gut (8.6 ± 0.7% at 1 hr) and subsequently excreted directly into the intestinal lumen and eliminated in feces.
The major portion of urinary excretion occurred early and accounted for 9% of the dose. The limited urinary excretion is likely due to the rapid decline in plasma radiolabel. The half-20 life of the P phase of the plasma concentration curve and the hepatic uptake half-life were identical, -7 min, suggesting that hepatic tissue binding was a major factor in tie kinetics of plasma elimination of [ 3 H]MCYST-LR. This is not surprising, as extravascular tissue binding is known to be a principal determinate of the apparent half-life of xenobiotics if VO is >100 ml/kg (Gibaldi and Perrier, 1982) . Drugs such as rifampicin that inhibit hepatic uptake of toxin (Pace et al., 1990a; Runnegar et al., 1981) increase its plasma half-life and thus may increase urinary excretion.
Unlike the hepatic-cytosolic radiolabel, urine and fecal radiolabel did not appear to be protein bound since pronase treatment was not required for sample preparation. Most of the radioactivity in both urine and feces was parent toxin (approximately 60%) and the metabolites that were detected did not appear to correlate with those seen in liver.
In a previous study, (Pace et al. 1990c) The decrease with time in amount of radiolabel that was covalently bound may represent a pathway by which the radiolabel would finally be eliminated from liver. There was not, however a strong numerical correlation between the appearance of the 8.1 min HPLC peak (or the appcarance/disappearance of any other HPLC peak) and the degree of covalent binding (Table 2 compared 
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,. 2 day 62 ± 3* 4 day 42 ± 10*"
6 day 42 ± 11i** aValues are mean ± SE, n=3.
bFractions 2 and 3 were added together and expressed as percent of total hepatic cytosolic radiolabel. P < 0.05 compared to 1 and 6 hr. P < 0.001 compared to 1, 6, 12 hr and 1 day. of liver cytosol were chromatographed on a 10-ml Bio-Gel P-6 column equilibrated with 100 mM Tris-Cl, pH 7.2 and l-ml fractions were collected. The solid line is a representative elution pattern from cytosol 2 days post injection. All the time points, 1 hr through 6 days, yielded similar results. The dashed line is the elution profile of ( 
Figure legends

